Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
tpv/ r
tpv/ r
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
new enf tpv/r
ny enf tpv/r
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
no new enf* tpv/r
ingen ny enf * tpv/r
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
number of tpv score mutations
antal af tpv score mutationer**
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
tipranavir/ritonavir (tpv+rtv)
tipranavir/ritonavir (tpv + rtv)
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
there was no relevant change in tpv cmin.
der var ingen relevante ændringer i tpv cmin.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
enf enfuvirtide; tpv/r tipranavir with ritonavir
enf: enfuvirtid; tpv/r: tipranavir med ritonavir
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
what aptivus looks like and contents of the pack aptivus soft capsules are pink coloured, with a black print imprint of tpv 250.
aptivus’ s udseende og pakningsstørrelse aptivus bløde kapsler er lyserøde med et sort påtrykt mærke tpv 250.
based on similarities in the elimination between pravastatin and rosuvastatin, tpv/r could increase the plasma levels of pravastatin.
på baggrund af lighederne i eliminationen mellem pravastatin og rosuvastatin, kan tpv/r øge plasmakoncentrationen af pravastatin.
the limited data available from a phase iia study in hiv-infected patients have shown a clinically non significant 20% decrease of tpv cmin.
de begrænsede data fra et fase iia studie hos hiv patienter har vist en 20% reduktion af tpv cmin, der ikke var klinisk signifikant.
-1.6 -1.1 -0.9 -0.8 -0.6 -1.0 * includes patients who did not receive enf and those who were previously treated with and continued enf ** **mutations in hiv protease at positions l10v, i13v, k20m/r/v, l33f, e35g, m36i, k43t, m46l, i47v, i54a/m/v, 58e, h69k, t74p, v82l/t, n83d or i84v enf enfuvirtide; tpv/r tipranavir/ritonavir
-1. 6 -1. 1 -0. 9 -0. 8 -0. 6 -1. 0 * omfatter patienter, som ikke har modtaget enf, samt de patienter, som tidligere er blevet behandlet med og har fortsat enf ** mutationer i hiv-protease ved positionerne l10v, i13v, k20m/r/v, l33f, e35g, m36i, k43t, m46l, i47v, i54a/m/v, 58e, h69k, t74p, v82l/t, n83d or i84v enf:enfuvirtid; tpv/r:tipranavir/ritonavir